Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
UNHCR Recognizes Climate-Resilient Drinking Water Planning Tool as Global Compact on Refugees Good Practice
-
SCHMID Group announces Agreement for New China Manufacturing Campus to Support Future Growth
-
Ballou named among Europe's best PR agencies while expanding U.S. client portfolio
-
Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle
-
Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy
-
Ballou named among Europe's best PR agencies while expanding U.S. client portfolio
-
From Store Manager to Franchise Owner: Body Energy Club Celebrates Ritesh’s Full-Circle Journey at Olympic Village Grand Opening June 13, 2026
-
Ongwe Minerals Discovers New Multi-Kilometer Gold Anomaly At Its Omatjete Gold Project In Namibia
-
Fredonia Mining Inc. Advances PEA and Expands District Position at El Dorado Monserrat
-
FLYR and Res2 Partner to Accelerate Order-Based Delivery
-
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safe
-
Verified Once, Trusted Forever? Regula to Discuss the Future of Age Assurance at Identity Week Europe 2026
-
Labrador Gold Announces Receipt of Class 1 Permit and Finalizes Contracts for Field Work at the Mariposa and Eureka Dome Projects, White Gold District, Yukon
-
Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration
-
BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board
-
Apollo Therapeutics Appoints Timothy P. Walbert as Chairman of the Board
-
Atavistik Bio Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation for ATV-1601 for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
17 Education & Technology Group Inc. to Report First Quarter 2026 Unaudited Financial Results on June 16, 2026
-
MindBio Completes Manufacture and Delivery of First Prototype Edge AI Intoxication and Fatigue Detection Kiosks
-
HR Tech 2026 Announces Initial Agenda: Focuses on Real-World AI Implementation, Skills, and Workforce Transformations
-
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
-
Synack Supports Majority of Cabinet-Level Federal Departments as New AI Executive Order Raises the Bar on Federal Security
-
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
-
Lahontan Drills 91m Grading 0.43 g/t Au Oxide at Calvada, Discovers New Gold Zone at Slab West
-
Revenium Launches AI Insights to Pinpoint and Rank Where Agentic AI Spend is Wasted
-
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
-
NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026
-
Evotrex Raises $30 Million Series A to Accelerate Production of the Evotrex-PG5 Electric RV Trailer
-
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases
-
NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University
-
Ridgepost Capital Announces Appointment of Vice President, Investor Relations
-
NIRI Twin Cities Chapter Elects 2026-2027 Board of Directors
-
AB InBev Argentina x SeenThis: Michelob ULTRA wins fan attention on the road to FIFA World Cup 2026™
-
American Fusion Inc. (OTC: AMFN) Provides Development and Testing Update for 5MW Pre-Production Texatron™ Fusion Engine™
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Investors of Blue Owl Capital Corp. III (NYSE: OBDE) Who Received Shares of Blue Owl Capital Corp. (NYSE: OBDC), and Former Investors of B
-
17 Education & Technology Group Inc. to Report First Quarter 2026 Unaudited Financial Results on June 16, 2026
-
With SOL Outpacing Every Major Blockchain in Q1 2026, Solana Unchained Moves to Capture the Next Wave of Ecosystem Growth
-
CECO Environmental Provides Post-Closing Update on Thermon Transaction
-
Village Farms Commences Cultivation in Phase II Facility in Netherlands
-
SailPoint Announces Fiscal First Quarter 2027 Results
-
Contentstack Introduces Its Agentic Experience Platform (AXP) With Agent OS and Agent Accelerator to Remove Roadblocks to Enterprise AI ROI and Adoption
-
Antag Therapeutics Elects Keith Leonard as Chairman of its Board of Directors
-
DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference
-
MitoRx Therapeutics Strengthens Leadership Team with C-Suite and Board Appointments to Support Next Phase of Growth
-
Holm Security expands platform with Active Directory Security to harden the most-targeted layer of business identity
-
Fury Engages Leading Firms to Advance Eau Claire Pre-Feasibility Study Work
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine
-
Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine
